Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
The use of antibiotics disrupts the ecology of the microbiome in three important ways. First, antibiotic therapy can lead to secondary infection, as in antibiotic-associated diarrhea caused by…
Multiple clinical trials are currently underway examining the possible synergistic effects of combining chemotherapy with immunotherapies for patients with bladder cancer and other metastases.
James Geiger, MD, professor of surgery at University of Michigan, and his colleague, professor of engineering, Shorya Awtar, have developed a low-tech, and relatively inexpensive surgical tool that…
Probiotics can both restore and establish the microbiome after disruption by antibiotics. When the microbiome is compromised by antibiotic therapy, resulting in conditions such as antibiotic-associated diarrhea, probiotics…
Neural networks (a.k.a. deep learning algorithms) can be used to teach computers to distinguish various types of disease via prior analysis of massive amounts of clinical data.
While influenza vaccination remains the top recommendation of physicians for protecting against the flu, there are other preventive measures that still need to become more widely adopted. Many…
The Proteomic Assessment of Preterm Birth (PAPR) study conducted by Sera Prognostics, Inc. has yielded information that led to the development of a test which can help physicians…
Each month we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
